Search for common haplotypes on chromosome 22q in patients with schizophrenia or bipolar disorder from the Faroe Islands
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Standard
Search for common haplotypes on chromosome 22q in patients with schizophrenia or bipolar disorder from the Faroe Islands. / Jorgensen, T H; Børglum, A D; Mors, O; Wang, A G; Pinaud, M; Flint, T J; Dahl, H A; Vang, M; Kruse, T A; Ewald, H; Børglum, A D.
I: American Journal of Medical Genetics, Bind 114, Nr. 2, 2002, s. 245-52.Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Search for common haplotypes on chromosome 22q in patients with schizophrenia or bipolar disorder from the Faroe Islands
AU - Jorgensen, T H
AU - Børglum, A D
AU - Mors, O
AU - Wang, A G
AU - Pinaud, M
AU - Flint, T J
AU - Dahl, H A
AU - Vang, M
AU - Kruse, T A
AU - Ewald, H
AU - Børglum, A D
N1 - Keywords: Bipolar Disorder; Chromosomes, Human, Pair 22; DNA; Denmark; Family Health; Female; Gene Frequency; Genotype; Haplotypes; Humans; Male; Microsatellite Repeats; Pedigree; Schizophrenia
PY - 2002
Y1 - 2002
N2 - Chromosome 22q may harbor risk genes for schizophrenia and bipolar affective disorder. This is evidenced through genetic mapping studies, investigations of cytogenetic abnormalities, and direct examination of candidate genes. Patients with schizophrenia and bipolar affective disorder from the Faroe Islands were typed for 35 evenly distributed polymorphic markers on 22q in a search for shared risk genes in the two disorders. No single marker was strongly associated with either disease, but five two-marker segments that cluster within two regions on the chromosome have haplotypes occurring with different frequencies in patients compared to controls. Two segments were of most interest when the results of the association tests were combined with the probabilities of identity by descent of single haplotypes. For bipolar patients, the strongest evidence for a candidate region harboring a risk gene was found at a segment of at least 1.1 cM including markers D22S1161 and D22S922 (P=0.0081 in the test for association). Our results also support the a priori evidence of a susceptibility gene to schizophrenia at a segment of at least 0.45 cM including markers D22S279 and D22S276 (P=0.0075). Patients were tested for the presence of a missense mutation in the WKL1 gene encoding a putative cation channel close to segment D22S1161--D22S922, which has been associated with schizophrenia. We did not find this mutation in schizophrenic or bipolar patients or the controls from the Faroe Islands.
AB - Chromosome 22q may harbor risk genes for schizophrenia and bipolar affective disorder. This is evidenced through genetic mapping studies, investigations of cytogenetic abnormalities, and direct examination of candidate genes. Patients with schizophrenia and bipolar affective disorder from the Faroe Islands were typed for 35 evenly distributed polymorphic markers on 22q in a search for shared risk genes in the two disorders. No single marker was strongly associated with either disease, but five two-marker segments that cluster within two regions on the chromosome have haplotypes occurring with different frequencies in patients compared to controls. Two segments were of most interest when the results of the association tests were combined with the probabilities of identity by descent of single haplotypes. For bipolar patients, the strongest evidence for a candidate region harboring a risk gene was found at a segment of at least 1.1 cM including markers D22S1161 and D22S922 (P=0.0081 in the test for association). Our results also support the a priori evidence of a susceptibility gene to schizophrenia at a segment of at least 0.45 cM including markers D22S279 and D22S276 (P=0.0075). Patients were tested for the presence of a missense mutation in the WKL1 gene encoding a putative cation channel close to segment D22S1161--D22S922, which has been associated with schizophrenia. We did not find this mutation in schizophrenic or bipolar patients or the controls from the Faroe Islands.
M3 - Journal article
VL - 114
SP - 245
EP - 252
JO - American Journal of Medical Genetics
JF - American Journal of Medical Genetics
SN - 0148-7299
IS - 2
ER -
ID: 34083514